These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 30925704)
1. Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age. Costa G; Porceddu PF; Serra M; Casu MA; Schiano V; Napolitano F; Pinna A; Usiello A; Morelli M Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925704 [TBL] [Abstract][Full Text] [Related]
2. Rhes Counteracts Dopamine Neuron Degeneration and Neuroinflammation Depending on Gender and Age. Costa G; Pinna A; Porceddu PF; Casu MA; Di Maio A; Napolitano F; Usiello A; Morelli M Front Aging Neurosci; 2018; 10():163. PubMed ID: 29904346 [TBL] [Abstract][Full Text] [Related]
3. Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent. Frau L; Costa G; Porceddu PF; Khairnar A; Castelli MP; Ennas MG; Madeddu C; Wardas J; Morelli M J Neurochem; 2016 Jan; 136(1):148-62. PubMed ID: 26442661 [TBL] [Abstract][Full Text] [Related]
4. MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice. Costa G; Frau L; Wardas J; Pinna A; Plumitallo A; Morelli M Mov Disord; 2013 Dec; 28(14):1957-65. PubMed ID: 24108425 [TBL] [Abstract][Full Text] [Related]
5. Involvement of the Protein Ras Homolog Enriched in the Striatum, Rhes, in Dopaminergic Neurons' Degeneration: Link to Parkinson's Disease. Serra M; Pinna A; Costa G; Usiello A; Pasqualetti M; Avallone L; Morelli M; Napolitano F Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070217 [No Abstract] [Full Text] [Related]
6. Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility. Frau L; Simola N; Plumitallo A; Morelli M J Neurochem; 2013 Jan; 124(1):69-78. PubMed ID: 23083295 [TBL] [Abstract][Full Text] [Related]
8. In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice. Costa G; Spulber S; Paci E; Casu MA; Ceccatelli S; Simola N; Morelli M Neurotoxicology; 2021 Mar; 83():1-13. PubMed ID: 33338551 [TBL] [Abstract][Full Text] [Related]
9. Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain. Frau L; Simola N; Porceddu PF; Morelli M Neurotoxicology; 2016 Sep; 56():127-138. PubMed ID: 27451954 [TBL] [Abstract][Full Text] [Related]
10. The Small GTP-Binding Protein Rhes Influences Nigrostriatal-Dependent Motor Behavior During Aging. Pinna A; Napolitano F; Pelosi B; Di Maio A; Wardas J; Casu MA; Costa G; Migliarini S; Calabresi P; Pasqualetti M; Morelli M; Usiello A Mov Disord; 2016 Apr; 31(4):583-9. PubMed ID: 26853527 [TBL] [Abstract][Full Text] [Related]
11. Caffeine enhances astroglia and microglia reactivity induced by 3,4-methylenedioxymethamphetamine ('ecstasy') in mouse brain. Khairnar A; Plumitallo A; Frau L; Schintu N; Morelli M Neurotox Res; 2010 May; 17(4):435-9. PubMed ID: 19882200 [TBL] [Abstract][Full Text] [Related]
12. Chronic methamphetamine-induced neurodegeneration: Differential vulnerability of ventral tegmental area and substantia nigra pars compacta dopamine neurons. Du Y; Lee YB; Graves SM Neuropharmacology; 2021 Dec; 200():108817. PubMed ID: 34610287 [TBL] [Abstract][Full Text] [Related]
13. The striatal-enriched protein Rhes is a critical modulator of cocaine-induced molecular and behavioral responses. Napolitano F; De Rosa A; Russo R; Di Maio A; Garofalo M; Federici M; Migliarini S; Ledonne A; Rizzo FR; Avallone L; Nuzzo T; Biagini T; Pasqualetti M; Mercuri NB; Mazza T; Chambery A; Usiello A Sci Rep; 2019 Oct; 9(1):15294. PubMed ID: 31653935 [TBL] [Abstract][Full Text] [Related]
14. Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesia. Brugnoli A; Napolitano F; Usiello A; Morari M Neurobiol Dis; 2016 Jan; 85():155-163. PubMed ID: 26522958 [TBL] [Abstract][Full Text] [Related]
15. Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit. Leino S; Koski SK; Hänninen R; Tapanainen T; Rannanpää S; Salminen O Neuropharmacology; 2018 Aug; 138():371-380. PubMed ID: 29940207 [TBL] [Abstract][Full Text] [Related]
16. Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence. Cadoni C; Pisanu A; Simola N; Frau L; Porceddu PF; Corongiu S; Dessì C; Sil A; Plumitallo A; Wardas J; Di Chiara G Neuropharmacology; 2017 Sep; 123():385-394. PubMed ID: 28603026 [TBL] [Abstract][Full Text] [Related]
17. Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration. Choi DY; Lee MK; Hong JT Neurobiol Dis; 2013 Jan; 49():159-68. PubMed ID: 22922220 [TBL] [Abstract][Full Text] [Related]
18. Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion. Ghiglieri V; Napolitano F; Pelosi B; Schepisi C; Migliarini S; Di Maio A; Pendolino V; Mancini M; Sciamanna G; Vitucci D; Maddaloni G; Giampà C; Errico F; Nisticò R; Pasqualetti M; Picconi B; Usiello A Sci Rep; 2015 Jul; 5():10933. PubMed ID: 26190541 [TBL] [Abstract][Full Text] [Related]
19. The involvement of brain-derived neurotrophic factor in 3,4-methylenedioxymethamphetamine-induced place preference and behavioral sensitization. Mouri A; Noda Y; Niwa M; Matsumoto Y; Mamiya T; Nitta A; Yamada K; Furukawa S; Iwamura T; Nabeshima T Behav Brain Res; 2017 Jun; 329():157-165. PubMed ID: 28472632 [TBL] [Abstract][Full Text] [Related]
20. Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice. Risbrough VB; Masten VL; Caldwell S; Paulus MP; Low MJ; Geyer MA Neuropsychopharmacology; 2006 Nov; 31(11):2349-58. PubMed ID: 16855533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]